Current biotech openings.

Lead protein engineering for multispecific biologics designed to improve immune engagement in solid tumors.

Build the biomarker strategy for a solid-tumor immuno-oncology program moving toward first-in-human studies.

Design edited donor-derived immune cells for an off-the-shelf cell therapy program aimed at solid tumors.

Run pooled CRISPR screens that identify disease-relevant targets in oncology and immune-biology models.

Build production NGS pipelines for oncology and inherited-disease clinical sequencing assays.

Develop ML models that help design and prioritize RNA therapeutic constructs before wet-lab testing.